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Detection of biomolecules is important in proteomics and clinical diagnosis and 
treatment of diseases. Here, we apply functionalized, macromolecular, single-walled 
carbon nanotubes (SWNTs) as multi-color Raman labels to protein arrays for 
highly sensitive, multiplexed protein detection. Raman detection utilizes the sharp 
peaks of SWNTs with minimal background interference, affording a high signal-to-
noise ratio needed for ultra-sensitive detection. Surface-enhanced Raman scattering 
(SERS) combined with the strong resonance Raman intensity of SWNTs, affords 
detection sensitivity down to 1 fM, a three order of magnitude improvement over 
most of reported fluorescence-based protein detections.  We show that human 
autoantibodies to Proteinase 3 (aPR3), a biomarker for the autoimmune disease 
Wegener's granulomatosis, is detected by Raman in human serum up to a 1:107 
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dilution. Moreover, SWNT Raman tags are stable against photobleaching and 
quenching, and by conjugating different antibodies to pure 12C and 13C SWNT 
isotopes, we demonstrate two-color SWNT Raman-based protein detection in a 
multiplexed fashion.  
Various methods have been developed for protein detection, including enzyme-
linked immunosorbent assays, fluorescence-based protein microarrays,1 
electrochemistry,2 label-free optical methods,3,4 surface-enhanced Raman scattering 
(SERS),5,6,7 microcantilevers,8 quantum dots,9,10 and nanotube11,12 or nanowire13 based 
field-effect transistors. Among them, protein microarrays14,15 are unique, providing high 
throughput, multiplexed protein detection, and thus have found wide application ranging 
from proteomics to disease research and diagnosis.14,16,17  The typical sensitivity limit of 
protein arrays based on fluorophore tags is ~1 pM, limited by background interference 
due to species on the substrate or autofluorescence of reagents.18 Increasing the 
sensitivity of protein detection in arrayed format could enhance the capability of this 
novel method for proteomics research.  Moreover, improved understanding of soluble 
biomarkers in diseases such as cancer has yielded clinical demands for high sensitivity 
and selectivity, thus allowing for minimally invasive risk assessment, early stage disease 
diagnosis, and monitoring of responses to therapeutic interventions.19  
A few diverse methodologies are under development which show promise for 
highly sensitive protein detection in research and clinical applications. Label-free 
nanowire-based transistors13 have demonstrated femtomolar sensitivity, but the 
sensitivity is limited to samples in pure water or low salt solutions, and not in serum. 
Another methodology, amplified detection based upon multi-functional nanoparticles, has 
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demonstrated even higher sensitivity,10 however this method’s complexity requires a 
multitude of reagents and is highly time consuming. The methodology described herein, 
based upon Raman scattering, is relatively simple, may be easily multiplexed, and 
exhibits high sensitivity in clinically relevant samples over a large dynamic range, from 
ng/mL to fg/mL. 
The SERS effect provides the potential for rapid, high throughput, sensitive 
protein detection. Previously, SERS was applied for immobilized protein detection5,6 by 
coupling small Raman-active dyes to gold nanoparticles functionalized by ligands.  
However, the utility of these sensors was limited in sensitivity as typical Raman labels 
have weak intensities, owing to small Raman scattering cross-sections.20 As a result, 
sensitivity is not quantitative5 or is limited to nM range5 which does not compare 
favorably with fluorescence methods. For high sensitivity Raman sensing with dye 
molecules,7 long acquisition times are needed and molecules are easily subject to 
degradation under laser radiation.  
Single-walled carbon nanotubes (SWNTs), on the other hand, are ideal labels for 
SERS-based protein detection.  SWNTs have unique one-dimensional structure, and 
exhibit distinct electrical and spectroscopic properties, including strong and simple 
resonance Raman signatures.  SWNTs posses enormous Raman scattering cross-sections 
(~10-21 cm2 sr-1 molecule-1), simple, tunable spectra, and are more stable than other 
organic Raman labels.21,22 Various schemes have been explored to develop SWNTs for 
chemical, biological and medical applications.23-27 Carbon nanotubes have been utilized 
as in vivo28 and in vitro29 optical probes for biological imaging, yet their potential as 
Raman-tags for highly sensitive detection applications has not been explored previously. 
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We describe the synthesis and preparation of biocompatible, highly selective SWNT-IgG 
conjugates for in vitro protein detection.  Novel methodology for obtaining uniform 
surface-enhanced Raman scattering over large areas has been developed and combined 
with well known self-assembly chemistry for robust protein immobilization coupled with 
high sensitivity Raman scattering detection.  
Herein, we report the use of SWNTs as macromolecular Raman labels for highly-
sensitive and selective arrayed protein detection, with 1000-fold greater sensitivity than 
fluorescence, over 7 to 8 decades of dynamic range for systems demonstrating high 
affinity interactions. We demonstrate detection of the clinically-relevant human 
autoimmune disease biomarker anti-Proteinase 3 (aPR3) in human serum down to 1:107 
dilution. Multiple-color SWNT Raman labels are developed using isotopic SWNTs, and 
employed for sensing in a multiplexed fashion requiring only a single excitation source.  
 
RESULTS  
Assay design for protein detection by SWNT Raman-tags 
A secondary antibody, goat anti-mouse immunoglobulin-G (GaM-IgG), was 
conjugated to highly water soluble, short (~50-150 nm, see Supplementary Fig. S1 
online), macromolecular SWNTs, functionalized with PEGylated phospholipids26 (PL-
PEG, see Methods).  GaM-IgG conjugation imparted binding specificity of SWNT-tags 
to mouse antibodies (Fig. 1). Protein immobilization on substrates was performed in 
arrayed fashion, by either covalent attachment to Au-coated glass or on commercial 
microarray slides by standard robotic spotting (see Method). We developed a novel 6-
arm-branched carboxylate-terminated PEG, grafted onto Au-coated surfaces for protein 
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immobilization (Fig. 1a), that afforded excellent protein attachment and high resistance 
to non-specific binding (NSB) effects. Proteins, such as polyclonal mouse IgG or human 
serum albumin (HSA), were immobilized on the assay surface and either detected by 
Raman scattering upon binding of GaM-IgG-conjugated SWNTs (using 785 nm 
excitation laser, see Methods), or were used in sandwich assays, to capture analyte 
protein (e.g., anti-HSA IgG raised in mouse) from dilute serum (Fig. 1b).   
 To enhance Raman scattering intensity following direct or sandwich assay 
detection of analyte by SWNT labeled GaM-IgG, we annealed the gold-coated substrate 
in a reducing hydrogen atmosphere to aggregate the Au film into particles 
(Supplementary Fig. S2 online for atomic force microscopy (AFM) images).  
Alternatively, a 5 nm layer of pure silver was deposited (Supplementary Fig. S3 online) 
onto the assay surface at ambient temperature (see Methods). Both techniques led to 
reproducible SWNT Raman signal enhancement of about 60-fold without damaging 
SWNTs, as evidenced by the observed strong, characteristic SWNT radial breathing 
mode (RBM, < 500 cm-1), longitudinal G+  and transverse G- mode (near 1590 cm-1) 
signals (Fig. 1c) uniformly over the substrate. The strong SERS effect was attributed to 
field enhancement by surface plasmons of metal particles, formed uniformly over the 
entire substrate, in near-resonance with the 785 nm laser used for Raman scattering 
measurements.  (Supplementary Fig. S4 online).30  For quantitative protein detection, 
the SWNT G-mode scattering intensity was utilized, as it demonstrates a high signal-to-
noise ratio and very narrow peak width (~20 cm-1 FWHM).31   
 
 Selective and sensitive detection of model proteins by SWNT-Raman tags  
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The selectivity of a protein assay depends on both effective antibody conjugation 
and the minimization of NSB.  In this study, single-walled carbon nanotubes were 
functionalized by a 1:1 mixture of phospholipid-branched-methoxyPEG (DSPE-3PEO), 
which provided excellent NSB resistance11,27,32 (see Supplementary Fig. S5 online), and 
linear phospholipid-PEG-NH2 (DSPE-PEG-NH2, see Methods), which provided sites for 
bioconjugation.  To evaluate the selectivity of this assay, different proteins were 
immobilized on PEGylated Au/glass substrates and tested for binding with GaM-
IgG/SWNTs through Raman detection (Fig. 2a). We observed specific GaM-IgG/SWNT 
binding only to the six mouse IgG’s immobilized on the substrate, and not to the other 
eight negative control protein spots (Fig. 2b).  The application of SWNT Raman tags in 
biomolecule detection is highly generalizable to any system with adequate binding 
affinity and specificity (A summary of biomolecules employed in SWNT Raman sensing 
and their affinities is provided in Supplementary Table S1 online).  In addition to 
Raman tags for protein assays, SWNTs have been utilized as tags for the in vitro Raman 
labeling of various cell membrane receptors,22,26,27,29,32 including both low and high 
affinity interactions, such as those between cyclic RGD peptide with the cell adhesion 
molecule αvβ3 integrin and anti-CD20 (Rituxan®) with CD20 respectively (see 
Supplementary Fig. S6, Fig. S7, Fig. S8, and Fig. S9 online for examples of specific 
detection over a wide range of binding affinities, including SWNT Raman tags used in 
biomolecular detection based upon streptavidin-biotin interaction, complimentary ssDNA 
binding, Protein A and Protein A/G – goat IgG interaction, and in vitro cyclic RGD 
peptide labeling of cell surfaces). 
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 To explore the sensitivity limit of SWNT Raman-based protein detection, human 
serum albumin (HSA) and GaM-IgG/SWNTs were used as model capture and reporting 
agents for sandwich assay detection of monoclonal mouse anti-HSA IgG (aHSA) spiked 
into fetal bovine serum (FBS, Fig. 1). Figure 3a shows Raman mapping images of HSA 
spots after exposure to various concentrations of aHSA from 100 pM to 1 fM followed by 
incubation with GaM-IgG/SWNTs. The images were generated by plotting the integrated 
SWNT G-band intensity at each point (50 μm x 50 μm pixel size) over one quarter of the 
protein spot.  In the maps, uniform SWNT signals were observed within HSA spots 
exposed to aHSA at concentrations above ~1 pM. At lower concentrations, the SWNT 
signal was sparse, consistent with a small number of aHSA IgGs captured by the HSA 
layer.  Defining the limit of detection (LOD) as twice the standard deviation above the 
control (without analyte), we reproducibly obtained aHSA detection sensitivity down to 1 
fM, over 8 orders of dynamic range (Fig. 3b, replicate sets of data are shown, obtained on 
independent assay chips with different batches of GaM-IgG/SWNT conjugates). The data 
exhibited sigmoidal or S-shape behavior,33 suggesting saturation and steric hindrance 
effects for detection at high concentrations, and increased proportional influence of 
residual NSB effects at the lower detection limit.  
To compare our SWNT-Raman-based detection to standard fluorescence-based 
protein microarray methods, we performed both assays in parallel. Protein microarray 
experiments were carried out on Super-Epoxide II slides (Array-It) by replacing the 
GaM-IgG/SWNT tags with cyanine-3 (cy3) labeled GaM-IgG. A LOD of ~1 pM of 
aHSA was reproducibly obtained with arrayed fluorescence detection (Fig 3c,d and Fig. 
S10), and this sensitivity limit was comparable to previous observations.1 For 
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fluorescence-based protein microarrays, we found that the fluorescence signals from 
HSA spots exposed to ≤ 100 fM analyte were similar to those measured at protein spots 
without any exposure to Cy3 labeled GaM-IgG.  This indicates that for detection of 
aHSA IgG concentrations ≤ 100 fM, fluorescence intensity was comparable to the 
background noise of substrates and reagent molecules, thus limiting the sensitivity to ~1 
pM. Conversely, in control experiments we observed no proteins or substrates exhibiting 
Raman peaks at the SWNT G-band position (Supplementary Fig. S11 online), providing 
little background interference.  Reduced background contribution and improved signal-
to-noise owing to bright Raman scattering spectra and surface-enhancement techniques 
provides an extended dynamic range in comparison to fluorescence-based techniques. 
Thus, the sharp, surface-enhanced, and background-free Raman scattering peaks 
observed in our detection method afforded ~1000-fold improved sensitivity over 
fluorescence methods in this model protein system.  
It should be noted that the inflection point slope of a dose-response curve is 
expected to be unity.  This is nearly observed for the fluorescence-based assay of aHSA 
(slope of 0.88), while SWNT-Raman tags show an inflection point slope of 0.60.  This 
deviation from theory may be due to non-linear effects of surface enhanced Raman 
scattering34.  Despite such effects, the observation of sufficiently large Raman signal 
change down to 1 fM is significant, and can be used to measure low concentrations. 
Curve fitting is a standard technique we employed to quantify our data in this 
concentration region, and sigmoidal (4-parameter logistic) regressions have adequately fit 
the data and allowed quantification.    
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To exemplify this, a blind study was conducted in which three samples with 
unknown concentrations of aHSA were prepared and run in parallel with standards. Each 
data point value was determined by averaging 9-duplicate microarray protein spots on the 
same assay substrate (Fig. 4).  The average intensity was taken as the average of the 
individual mean scattering intensities (n=9), and error bars were calculated from the 
standard deviation between the mean scattering intensities of the nine duplicate spots.  
Such treatment yielded a calibration curve well fit by a logistic regression (Fig. 4) over 6 
orders of magnitude along with mean scattering intensities for the three unknowns and an 
analyte-free control.  Note that only six decades of analyte concentration were used for 
the calibration curve to avoid overcrowding of the substrate, and possible cross-
contamination.  The three unknowns were prepared as 5 pM, 200 fM and 5 fM analyte 
solutions.  Sensitivity down to the fM range, within a factor of two to three was observed, 
with the three blind unknown analyte samples quantified experimentally as 2 pM, 110 fM, 
and 4 fM respectively, thus demonstrating the accuracy of SWNT Raman-tag detection 
despite non-linear effects.  
  
Highly sensitive autoimmune biomarker detection in human serum 
We then applied our SWNT Raman labels to clinically-relevant detection related 
to Wegener’s granulomatosis (WG), an autoimmune disorder associated with anti-
neutrophil cytoplasmic antibodies (cANCA).35 The disease is characterized by multi-
organ vasculitis and can be fatal in severe cases. Currently, the gold standard for WG 
diagnosis and treatment is immunohistological staining; however, the positive predictive 
value is only ~50%.35  Autoantibodies directed against Proteinase 3 (PR3), a 29 kDa 
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serine protease, are directly implicated in the pathogenesis of WG, and are used for 
diagnosing WG.  Immunoassays for aPR3 have proven more effective in prediction of 
WG flares than staining alone.36 We synthesized goat anti-human (GaH) secondary 
antibody, GaH-IgG/SWNT, Raman tags for detection of human aPR3 in human serum, 
mimicking the serum of a WG-positive patient.  A human IgG sample containing aPR3 
isolated from a c-ANCA-positive patient (Immunovision) was diluted 1:100 to 
1:10,000,000, all in 1% normal human serum (Fig. 5a).  A normal human serum sample, 
without spiked aPR3 (control), was included as a negative control.  Detection of aPR3 by 
the SWNT Raman method in comparison with the negative control sample was 
successful over more than 7 decades of dilution (Fig 5b). A sigmoidal dependence, 
modelled by four parameter logistic fit, blue curve, was observed, and the inflection point 
slope was approximately 0.50. Using Cy3 fluorescently-labeled GaH-IgG, the LOD was 
reached at only 4 orders of dilution of the original aPR3-spiked human serum solution. 
Beyond that, the signals were comparable to the background noise, measured from the 
normal human serum control (Fig. 5c). A sigmoidal dependence was fit by four-
parameter logistic function, red curve (inflection point slope was approximately 0.90).   
 
Multi-color detection by SWNT Raman-labels  
 Finally, SWNT Raman tags may be applied for multi-color detection.  This was 
accomplished by synthesizing 12C and 13C isotopic SWNTs by chemical vapor 
deposition37,38 using 12C- and 13C-pure methane respectively.  The Raman mode 
frequency scales with atomic mass as39 ω∝m-1/2. The G-band Stokes’ shift of pure 13C 
SWNTs (ωC13) relates to that of pure 12C SWNTs (ωC12=1590 cm-1) by ωC13=[1-
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(12/13)1/2]ωC12=1528 cm-1, as observed experimentally (Fig. 6b).  By comparing the 
Raman scattering intensity of 12C and 13C SWNT G-bands at their respective maxima, 
approximately 0.5% cross-talk was observed for the isotopomers (see Supplementary 
Fig. S12 online), Through differential conjugation of minimally cross-reactive secondary 
IgGs, SWNTs could be utilized for detecting two types of IgGs simultaneously. GaM and 
GaH IgGs were conjugated to 12C SWNTs (12C-GaM) and 13C SWNTs (13C-GaH), 
respectively.  A mixture of the two conjugates was incubated on the sensing assay 
surface, leading to differential binding to mouse and human primary IgGs with high 
selectivity (Fig. 6a, Supplementary Fig. S13 online).  More colors may be utilized by 
varying the 12C/13C ratio during growth (Supplementary Fig. S14 online), or by 
monitoring the radial breathing modes of diameter-separated SWNTs40. This may lead to 
many-color SWNT tags for multiplexed protein and biomarker assays41.  
 
DISCUSSION 
Highly selective and sensitive protein detection has been accomplished via SWNT 
Raman tags.  Their high scattering cross-section, resonant-enhancement, simple spectra, 
and facile isotopic tuning make SWNTs ideal Raman tags for sensitive detection of 
proteins and other biomolecules.  The development of a branched-PEG coating providing 
both amine functionality and inert methoxy termini on PEGylated SWNTs enabled 
production of target-specific, biocompatible nanotubes with minimal non-specific 
interactions between surfaces, proteins, and SWNTs.  Optimization of the SWNT-
antibody conjugates required almost two years to develop, as other attempts at 
functionalization led to unacceptable NSB between proteins and nanotubes,  and even 
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small degrees of NSB prevented protein detection at the 1-100 fM level due to false 
signal.   
 The coupling of spatially uniform SERS-active gold or silver structures to SWNT 
Raman tags allowed increased signal-to-noise ratios for protein detection, reducing assay 
time and improving the limits of detection.  The sharp SWNT Raman scattering peaks 
were not plagued by quenching in proximity to metal surfaces, as is observed with typical 
fluorescent dyes. This allows for microarrays performed on a variety of metal-coated 
substrates, utilizing well-established surface chemistry for optimal selectivity and 
sensitivity of protein detection. 
 While our current method of SERS (using random metal clusters) allows limits of 
detection 1000-fold lower than fluorescence-based methodologies, individual SWNT 
Raman tags likely experience a range of scattering enhancement-factors, depending on 
the location of nanotubes relative to metal structures, the local field enhancement of 
SERS hot spots, and the spatial and statistical distribution thereof. Small numbers of the 
“brightest” SERS hotspots exist and yet may contribute to the majority of the total 
signal34.  In SWNT-based protein detection, aggregation of a gold thin-film into 
nanostructures occurs after the statistical binding of IgG/SWNT tags to immobilized 
analyte. At relatively high concentrations, SWNTs occupy the small percentage of 
locations yielding the greatest surface enhancement (i.e. saturation), consequently 
contributing the majority of the total intensity in a non-linear fashion.  At reduced analyte 
concentrations, the spatial distribution of bound SWNT tags is too few to statistically 
occupy such hotspots, leading to a proportionally increased contribution of lesser 
enhanced SWNTs to the average intensity at each concentration.  Such dependence yields 
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a dose-response curve demonstrating sensitivity to analyte concentration in a non-linear 
manner. 
 While SERS and saturation effects contribute to the non-linearity of dose-
response quantification, the observation of sufficiently large surface-enhanced Raman 
signal change down to 1 fM of model analyte is highly significant, owing to improved 
signal-to-noise ratios and reduced background intereference. Logistic (4 parameter) curve 
fitting was employed to aid in accurate quantification of unknown analyte samples, and 
was proven effective in this regime for quantifying both model analyte, and for a true 
biomarker of human disease in human serum.   
 In summary, we used antibody-tagged SWNTs as multi-color Raman labels for 
detection of proteins in microarrays on various surfaces. Novel functionalization and 
bioconjugation chemistry of SWNTs, combined with protein immobilization on 
PEGylated, Raman-enhancing surfaces has allowed application of the sharp, background-
free Raman signatures of SWNTs in protein detection, resulting in reproducible 
sensitivity down to 1 fM (or 0.15 pg/mL) of analyte. In all cases, the SWNT assay was 
found to be three orders of magnitude greater than standard fluorescence assays.  This 
methodology was then applied to the clinically relevant detection of an autoimmune 
disease biomarker, anti-Proteinase 3. While this work has focused on antibody-antigen 
interactions, the application of SWNT Raman tags in specific biomolecule targeting and 
detection is highly generalizable. Future work and application of ultra-bright, 
background-free, multi-color SWNT Raman labels is exciting, with a goal of 
simultaneous detection of multiple analytes in complex fluids, with 1 fM sensitivity in a 
multiplexed, arrayed fashion.  
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METHODS  
SWNT-antibody conjugates.  SWNTs in this study were either raw HipCO SWNTs 
(Carbon Nanotechnologies Inc.) or iron ruthenium bimetallic catalyzed37 chemical vapor 
deposition (CVD) SWNTs (12C- and 13C-methane38 as the gas sources respectively).  
Aqueous SWNT suspensions were prepared by 1 h bath sonication of an aqueous solution 
of a 1:1 mole ratio mixture of 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE)-
PEG5000-3PEO (Mn ~ 8000) (Polyethylene Oxide) and DSPE-PEG5000-NH2 surfactants 
(NOF corporation), as described previously.25,26,42  
To conjugate goat anti-mouse  IgG (GaM-IgG) or goat anti-human IgG (GaH-IgG, 
Pierce) to SWNTs, first Traut’s Reagent (Pierce) was used to thiolate primary amines on 
the IgG. Sulfo-SMCC (sulphosuccinimidyl 4-N-maleimidomethyl cyclohexane-1-
carboxylate, Pierce) was mixed at a 1:5 molar ratio with the SWNT suspension and 
incubated at pH 7.4 for 2 h at room temperature. The excess sulfo-SMCC was then 
removed by centrifugal filtration through a 100 kDa molecular weight cutoff membrane 
(Millipore). After filtration, a 10-fold molar excess of thiolated GaM-IgG (or GaH-IgG) 
was added into the SWNT suspension and reacted overnight in PBS at 4 ºC. Excess 
unconjugated IgGs were removed by filtration.  The antibody-conjugated, short SWNTs 
(50-150 nm long) were characterized by atomic force microscopy (Nanoscope IIIa, 
Veeco). 
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Protein arrays for Raman assay. Au (5 nm Au/0.2 nm Ti) coated glass slides were 
washed and oxygen plasma treated (Gabler Labor Instrument) and immersed into a 5 mM 
cysteamine (Aldrich) ethanol solution overnight. The substrate was then immersed for 2 h 
in a DMF solution containing 0.1 mM 6arm-PEG-COOH (Mn ~ 10,000, see 
Supplementary Information online for details), 50 mM 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC, Aldrich) and 50 mM N-
hydroxysuccinimide (NHS, Pierce) to form Au surfaces coated with branched PEG (See 
Supplementary Fig. S15 online for surface hydrophilicity characterization).  Then, 0.5 
μL of 1 μM protein (e.g. HSA or PR3) solution was spotted via pipette and incubated on 
the EDC/NHS activated branched-PEG coating for 2 h in PBS at pH 7.2. The substrates 
were immersed in 0.1 M tris in PBS solution for 1 h to quench the reaction.  The 
substrates were then immersed into 3% fetal bovine serum (FBS) and 0.5% w/v tween-20 
(Aldrich) PBS solution overnight at 4 ºC for blocking. For multi-color Raman detection, 
1 μM purified human IgG and mouse IgG were printed in two sets each of triplicate 400 
μm diameter protein spots via solid printing pins (Array-It) with the robotic Bio-Rad 
VersArray Compact array printer on Superfrost Plus glass slides (Fisher) at 25 ºC and 
65% humidity.  
  
Protein Raman detection. For two-layer direct detection of immobilized proteins (Fig. 
2), 20 nM GaM-IgG/SWNT in PBS (molar extinction coefficient of short SWNTs43 
ε808nm ≈ 0.0079 nM-1cm-1) solution was incubated on the surface for 30 min to allow 
binding prior to Raman detection. For sandwich detection of aHSA, eight aHSA solutions 
(10 nM – 1 fM in 3% FBS / PBS) were incubated on the substrate containing an array of 
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HSA spots (above) for 24 hours at 4 ºC.  A 3% FBS/PBS solution without aHSA was 
incubated with an HSA protein spot, and served as an analyte-free control. A 
hydrophobic PAP marker (Cedarlane Labs) was used to circumscribe the array prior to 
incubation. Following PBS soaking for 5 min and gently rinsing with PBS and water, 20 
nM GaM-IgG/SWNT solution was incubated for 30 mins at room temperature. For aPR3 
detection, all aPR3 (Immunovision) solutions were prepared by spiking analyte into 1% 
normal human serum and 3% FBS in PBS. The total human IgG content in the original 
aPR3-containing sample, determined by ELISA, was 17 mg/mL. Ten serially-diluted 
aPR3 serum solutions, as well as an aPR3-negative, dilute normal human serum sample, 
were incubated on PR3 spots for 24 hour at 4 ºC. 20 nM GaH-IgG/SWNT conjugates 
were then incubated on the spots, allowing binding before Raman detection.  
For SERS, assays on gold substrates were annealed in protective hydrogen gas at 
400 °C for 3 minutes to form Au clusters over the substrates, which enhanced the SWNT 
Raman signals. Alternatively, for assays on glass substrates, as in the multi-color 
experiments, SERS was afforded by depositing a 5 nm thick Ag film on the substrate by 
electron beam evaporation. Ag clusters were formed uniformly over the substrate, coating 
the intact proteins and SWNT-tags. All Raman spectra were collected on a Renishaw 
micro-Raman instrument (laser excitation wavelength at 785 nm). A 20X objective lens 
(Leica) was used to focus on the protein spots. A laser spot of ~200 μm2 was utilized 
during the Raman scattering measurements. At each protein spot, at least 20 spectra were 
recorded at different spatial points to obtain an averaged SWNT Raman scattering 
intensity, as well as the standard deviation, depicted as error bars. The collection time for 
each spectrum was 1 second. For Raman imaging of protein array spots (Fig. 3a), Raman 
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mapping was carried out using a 20X objective, and the integrated G-band intensity was 
measured over the whole protein spot (approx. 3 mm2), pixel by pixel (pixel size 50 μm x 
50 μm).  Error bars for map analyses were generated as the standard deviation of the 
means of duplicated assay spots (n=9) 
 
12C and 13C SWNT direct IgG detection assay. A solution comprising a mixture of ~5 
nM 12C GaM-IgG/SWNT and ~5 nM 13C GaH-IgG/SWNT conjugates in PBS was 
incubated over robotically-printed polyclonal mouse and human IgG spots on Superfrost 
Plus glass slides (Fisher) for 30 min at room temperature. Following Ag deposition, 
mapping of the SWNT G band intensity over the 2 mm x 3 mm area was performed with 
30 μm steps in x and y. The MIgG and HIgG mapping image was generated by 
integration of the respective G-bands of 12C and 13C SWNTs above background, and 
plotted as false-colored maps (Fig. 6c). 
  
Standard fluorescence-based protein microarray assay. For fluorescence-based16 
aHSA and aPR3 detection, arrays of six duplicate protein spots were printed robotically. 
HSA was printed at 1 μM in PBS on Super-Epoxide 2 (Array-It) slides, and PR3 was 
printed at 0.2 mg/mL in PBS onto nitrocellulose-coated FAST slides (Whatman). Arrays 
were blocked for 1 h at room temperature in PBS with 0.05% Tween-20 and 3% FBS, 
and then incubated for 3 - 24 hours at 4 °C with the indicated dilutions of aHSA (in 3% 
FBS/PBS) or aPR3 (in 1% human serum and 3% FBS/PBS), in addition to unspiked 
serum controls. Following washing, arrays were incubated with 400 μL of a 10 pM 
solution of GaM-IgG/Cy3 or GaH-IgG/cy3 in16 PBS for 1 h at room temperature in the 
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dark. The slides were scanned using a GenePix 4000B Scanner (Axon Labs) with a 17 
mW, 532 nm excitation laser and photo-multiplier tube gain set to 400 for nitrocellulose-
coated slides (Whatman) and 800 for Super-Epoxide II Slides (Array-It). Array spot 
features were automatically selected at 10 μm pixel resolution by GenePix Pro 6.0 
software (Axon Labs).  Reported fluorescence values were calculated as the local 
background corrected (See Supplementary Information online) mean of all pixels 
identified as array features for each analyte dilution point.  Error bars represent the 
standard deviation between duplicate spots from the same assay substrate.   
 
Note: Supplementary information is available on the Nature Biotechnology website. 
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Figure Captions:  
 
Figure 1 Carbon nanotubes as Raman labels for protein microarray detection. (a) A 
schematic of surface chemistry used for immobilization of proteins on Au coated glass 
slides for Raman detection of analytes by single-walled carbon nanotube (SWNT) 
Raman-tags.  A self-assembled monolayer of cysteamine on Au was covalently linked to 
6-arm branched poly(ethylene glycol)-carboxylate (6arm-PEG-COOH, inset) to provide a 
layer with high resistance to protein non-specific binding, and terminal carboxylate 
groups for immobilizing proteins. (b) Sandwich assay scheme. Immobilized proteins in a 
surface spot were used to capture an analyte (antibody) from a serum sample. Detection 
of the analyte by Raman scattering measurement was carried out following incubation of 
SWNTs conjugated to goat anti-mouse antibody (GaM-IgG/SWNTs), specific to the 
captured analyte. SWNTs were functionalized by (1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-poly(ethylene oxide) (DSPE-3PEO) and 1,2-distearoyl-sn-glycero-
3-phosphoethanolamine (DSPE-PEG5000-NH2) (left panel). (c) SWNT Raman spectra in 
the G mode and radial breathing mode (RBM, inset) regions before and after SERS 
enhancement.  
 
Figure 2 Highly-selective recognition of surface-bound proteins by SWNT-antibody 
conjugates. (a) A schematic illustration of 2-layer, direct assay of mouse IgGs, which are 
immobilized with a complex set of protein analytes including BSA, Human IgGs and 
Avidin, arrayed on a Au/glass substrate by detecting GaM-IgG/SWNT Raman intensities. 
(b) G-mode intensities of GaM-IgG/SWNT conjugates bound to various protein spots on 
the substrate. Specific target proteins that were detected included polyclonal MIgG 
(Sigma), mouse anti-PSA (anti prostate specific antigen, Fitzgerald), mouse anti-TNF 
(Tumor Necrosis Factor, Pepro Tech. Inc.), mouse aHSA (Medix MAB Inc.), mouse aIL1 
(anti interleukin-1, Fitzgerald) and mouse aHCG (anti human chorionic gonadotropin, 
Biospacific).  Negative control proteins included human IgG (HIgG, Sigma), Streptavidin 
(SA, Pierce), PSA (Fitzgerald), BSA (bovine serum albumin, Pierce), HSA (Sigma), 
HCG (Biospacific), TNF (Pepro Tech. Inc.), AV (Avidin, Sigma). PBS (Fisher) was also 
spotted on the surface as a control. 
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Figure 3 Femtomolar protein detection using SWNT Raman labels, in comparison with 
fluorescence-based protein microarray detection. (a) Raman mapping images showing 
integrated SWNT G-band peaks for model protein sandwich assays of anti-human serum 
albumin (aHSA) in fetal bovine serum (FBS) ranging in concentration from 100 pM to 1 
fM and an FBS control. Scale bar is 300 μm. (b) A log-log plot of the G-band Raman 
intensity vs. aHSA concentration from two separate trials (blue and green) performed 
using different substrates and different GaM-IgG/SWNT conjugate batches on different 
days. A sigmoidal dependence was observed (and fit by four-parameter logistic function, 
red curve) suggesting that protein quantification by Raman scattering of SWNT-tags is 
limited by surface-receptor saturation and steric hindrance at high concentrations, and by 
residual NSB at the lower detection limit.  (c) Fluorescence-based microarray detection 
of aHSA. The image shows GaM-IgG/Cy3 fluorescence levels of HSA array spots 
exposed to aHSA ranging in concentration from 1 nM – 1 fM (a sigmoidal dependence, 
modelled by four parameter logistic fit, blue curve, was observed).  The fluorescence of 
aHSA bound to HSA on the substrate was also recorded without exposure to GaM-
IgG/Cy3 as a measurement of autofluorescence and background noise.  (d) Mean 
fluorescence vs. analyte concentration from 1 nM to 1 fM. FBS-only and fluorophore-
free controls are also included in the plot.  Fluorescence observed for HSA array spots 
exposed to aHSA at concentrations below 1 pM was not distinguishable from background 
fluorescence (without exposure to the Cy3 fluorophore), indicating that sensitivity was 
limited by poor signal-to-noise.   
 
Figure 4  Calibration curve of mouse anti-human serum albumin measured in microarray 
format from nine duplicate protein spots at each analyte concentration by SWNT Raman 
tags.  A limit of detection at 1 fM is observed with a dynamic range greater than 6 orders 
of magnitude.  A sigmoidal curve was obtained by four-parameter logistic function fitting 
of the data, red curve.  Blind unknown analyte samples were prepared at 5 pM, 200 fM, 
and 5 fM, and in comparison with the calibration curve, they were accurately quantified 
as 2 pM, 110 fM, and 4 fM respectively with this methodology.   
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Figure 5 Raman vs. fluorescence-based protein microarray detection of aPR3, a 
biomarker for Wegener’s granulomatosis (WG), in human serum. (a) Schematic 
illustration of specific detection of aPR3 spiked into dilute human serum. aPR3 is 
captured by PR3 antigen on a PEGylated, gold-coated substrate, and detected by anti-
human IgG conjugated SWNT Raman tags. (b) SWNT G-mode intensity as a function of 
aPR3 analyte concentration, captured from dilute human serum. The data shows two 
separate sensing trials, using different assay substrates and different batches of GaH-
IgG/SWNTs. Deviation in signal intensity is systematic, and likely a product of deviation 
in gold-thickness on the assay substrate and slight variation in the loading efficiency of 
anti-human IgG to the nanotube tags from batch to batch.  Our assay design, like most 
bioassays, requires the use of simultaneous calibration curve measurements on the same 
chip.  Accurate determination of unknown concentrations is possible because all 
measurements, standards and unknowns, are performed with the same reagents on the 
same assay substrate (See Figure 4 for such an example). A sigmoidal dependence was 
observed (and fit by four-parameter logistic function, red curve) suggesting that protein 
quantification by Raman scattering of SWNT-tags is limited by surface-receptor 
saturation and steric hindrance at high concentrations, and by residual NSB at the lower 
detection limit.  (c) Mean fluorescence as a function of aPR3 concentration captured from 
dilute human serum in a microarray experiment parallel to that described in (b) (a 
sigmoidal dependence, modelled by four parameter logistic fit, blue curve, was observed).  
 
Figure 6 Multi-color SWNT Raman labels for multiplexed protein detection. (a) 
Schematic illustration of two-layer, direct, microarray-format protein detection with 
distinct, Raman labels based upon pure 12C and 13C SWNT tags. 12C and 13C SWNTs 
were conjugated to GaM and GaH-IgGs, respectively, providing specific binding to 
complimentary IgGs of mouse or human origin, even during mixed incubation with 
analyte (as shown).  (b) G-mode Raman scattering spectra of 12C (red) and 13C (green) 
SWNT Raman-tags are easily resolvable, have nearly identical scattering intensities, and 
are excited simultaneously with a 785 nm laser. This allows rapid, multiplexed protein 
detection.  c) Raman scattering map of integrated 12C (red) and 13C (green) SWNT G-
 27
mode scattering above baseline, demonstrating easily resolved, multiplexed IgG detection 
based upon multi-color SWNT Raman labels. 
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Figure 2  
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Figure 3  
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Figure 4 
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Figure 5  
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Figure 6  
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